Heart surgery is done to correct problems with the heart. More than half a million heart surgeries are done each year in the United States for a variety of heart problems. Heart surgery is used to correct heart problems in children and adults. This article discusses heart surgeries for adults. For more information about heart surgeries for children, see the Diseases and Conditions Index articles on congenital heart defects, holes in the heart, and tetralogy of Fallot.
The most common type of heart surgery for adults is coronary artery bypass grafting (CABG). During CABG, surgeons use healthy arteries or veins taken from another part of the body to bypass (that is, go around) blocked arteries. CABG relieves chest pain and reduces the risk of heart attack.
Long-term morbidity as well as a lower level of education and employment rate are common among adults who underwent congenital heart surgery during childhood, regardless of the severity of the defect.
The United States military has a constant need for service members who can serve in elite and specialized military units, such as the Marine Corps. However, because the training courses for these forces is so rigorous, the dropout rate is high.
All Australians living with symptoms of severe aortic stenosis no longer face open heart surgery as the only treatment option, with public access to a less invasive therapy – previously reserved for only the sickest patients – now available to all Australians requiring treatment.
Nearly 10 percent of patients who are prescribed opioid medications following heart surgery will continue to use opioids more than 90 days after the procedure, according to a new study led by researchers in the Perelman School of Medicine at the University of Pennsylvania.
QUT, in partnership with Children’s Health Queensland, will lead a nation-wide study to help health services support the long-term neurodevelopment and quality of life of children with congenital heart disease.
Researchers at Baylor College of Medicine are recommending that all COVID-19 patients admitted to the ICU undergo a thromboelastography to test for the risk of forming blood clots.
A University of Cincinnati physician-researcher says unlocking the key to how platelets function before, after and during transcatheter aortic valve replacement (TAVR) may provide insight as to why some patients undergoing the heart procedure have better outcomes than others.
A new type of immunotherapy treatment for metastatic non-small cell lung cancer (NSCLC) is being tested by Missak Haigentz, Jr., MD, medical director of hematology and oncology for Atlantic Health System.
As the novel coronavirus spread across the globe in early 2020, hospitals worldwide scaled back medical procedures, including life-saving heart surgery, to deal with the emerging threat of COVID-19.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
Elective dental procedures have been restricted globally due to the Covid-19 pandemic. Novel innovation enables professional-level oral hygiene at home.
Treating hospitalized COVID-19 patients with anticoagulants-;blood thinners that slow down clotting-;may improve their chances of survival, researchers from the Mount Sinai COVID Informatics Center report.
Transcatheter aortic valve replacement is a revolutionary technology for the treatment of patients with severe calcific aortic stenosis.
Patients who underwent transcatheter aortic valve replacement (TAVR) did not have a higher rate of death at one year compared with those who had their heart valve replaced via open-heart surgery, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
Transcatheter aortic valve replacement procedures had a high rate of success and low risk of death or disabling stroke at 30 days in patients with a bicuspid, or two-leaflet, aortic valve, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
Lung cancer is the leading cause of cancer-associated deaths in the United States. Non-small cell lung cancer (NSCLC), a group of lung cancers named for the kinds of cells found in the cancer, constitutes more than 80% of all lung cancer cases.
Keck Medicine of USC urologists are launching a clinical trial to evaluate the effectiveness of spinal cord stimulation in patients with an overactive bladder due to neurological conditions, such as a spinal cord injury or stroke, and idiopathic (unknown) causes.
Experts from Northumbria and Sheffield Hallam Universities will launch a new research project which aims to increase patient uptake of cardiac rehabilitation programs as part of the NHS long-term plan.
Cardiologists at The Ohio State University Wexner Medical Center are the first in the United States to test a new type of ablation technology for patients suffering from atrial fibrillation, a common type of irregular heartbeat.
A group of researchers led by Professor Yoshiki SAWA of the Cardiovascular Group in the Graduate School of Medicine, Osaka University, succeeded in beating-heart surgery to repair a mitral valve.